ESG-IRMNCT04945473
Gastric Recalibration After Endoscopic Sleeve Gastroplasty
At risk: Primary completion moved at least 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 4 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Sep 2026 to Sep 2027 Show 4 more changesShow less
- Eligibility criteria expanded, about 19 words
- Secondary endpoints: details revised at 9 of 9 entries
- Study description revised
- Publications: details revised at 6 of 6 entries
- Notable Primary and study completion dates pushed to Sep 2026
- Start date: Jul 8, 2021 to Jul 13, 2021
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Primary completion date: May 2025 to Aug 2025
- Study completion date: May 2025 to Sep 2025
- Start date changed from estimate of Jul 2021 to Jul 8, 2021
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Total weight loss (TWL)
Timeframe: 3, 6, 12, 18 and 24 months after the ESG
Secondary (6)
Excess weight loss (EWL)
Body mass index (BMI)
Self-esteem and activities evaluation
Gastrointestinal quality of life evaluation
Comorbidity evolution
Show 1 moreShow less
Gastric Emptying evaluation
Arms and interventions
RevisionExperimental
BMI≥30 or total weight loss (TBWL) \< 10% and relaxation of gastric tubulisation at 6 months after ESG. Additional stitches will be placed during the follow-up gastroscopy at 6 months.
Without revisionNo intervention
The control gastroscopy will be performed without any additional procedure (no additional stitches).
Procedures: Endoscopic placement of additional sutures
Sites
1 site in 1 country
- Service de chirurgie digestive et endocrinienne, NHCStrasbourg, France